<SEC-DOCUMENT>0001437749-13-014725.txt : 20131114
<SEC-HEADER>0001437749-13-014725.hdr.sgml : 20131114
<ACCEPTANCE-DATETIME>20131114085455
ACCESSION NUMBER:		0001437749-13-014725
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20131114
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20131114
DATE AS OF CHANGE:		20131114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		131216960

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20131113b_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD><TITLE>bkyi20131113b_8k.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-FAMILY: Times New Roman; MARGIN-LEFT: 10px; FONT-SIZE: 10pt; MARGIN-RIGHT: 10px">
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA3><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B></B></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>UNITED STATES</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA4><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA5><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA6><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Washington, D.C. 20549</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA7><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA8><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>FORM 8-K</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA9><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA10><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>CURRENT REPORT</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA11><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA12><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA13><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA14><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): November 14, 2013</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA15><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=TBL39  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA17><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 18pt"><B>BIO-key International, Inc.</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA20><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt">&nbsp;</P></TD></TR>
<TR>
<TD style="WIDTH: 33.7%; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA21><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>Delaware</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA22><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(State or other jurisdiction of </FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">incorporation)</FONT></P></TD>
<TD style="WIDTH: 33.7%; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA23><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>1-13463</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA24><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(Commission File Number)</FONT></P></TD>
<TD style="WIDTH: 33.7%; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA25><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>41-1741861</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA26><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA27><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>&nbsp;</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA28><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>3349 Highway 138, Building D, Suite B</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA29><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>Wall, NJ&nbsp;07719</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA30><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(Address of principal executive offices)</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA31><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA32><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>(732)&nbsp;359-1100</B></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA33><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</FONT></P></TD></TR>
<TR>
<TD style="WIDTH: 101.1%; VERTICAL-ALIGN: top" colSpan=3>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA34><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction A.2 below):</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt" id=PARA35><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&#9744;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt" id=PARA36><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&#9744;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt" id=PARA37><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&#9744;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; MARGIN: 0pt 0pt 0pt 18pt" id=PARA38><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&#9744;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"> Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></P></TD></TR></TABLE>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA40.1>&nbsp;</P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK40 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR40 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM40 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR40 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA40.2>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA41><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.</B></FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA42>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; MARGIN: 0pt" id=PARA43><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">On November 14, 2013, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for its third quarter of 2013. A copy of the press release issued by the Company on November 14, 2013 is attached as Exhibit&nbsp;99. </FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA44>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA45><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA46>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA47><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA48>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA51><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements, Pro Forma Financial Information and Exhibit.</B></FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA52>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA53><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA54>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA55><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release, dated November 14, 2013, issued by </FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">the Company.</FONT></P>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA89.1>&nbsp;</P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK89 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR89 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM89 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR89 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA89.2>&nbsp;</P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA59><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>SIGNATURES</B></FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA60>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; MARGIN: 0pt" id=PARA61><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA62>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; MARGIN: 0pt" id=PARA63>&nbsp;</P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB69  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD width=718>&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top" colSpan=2>
<P style="LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA65><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">BIO-KEY INTERNATIONAL, INC.</FONT></P></TD></TR>
<TR>
<TD width=718>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA66><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Date: November 14, 2013</P></FONT></TD>
<TD style="VERTICAL-ALIGN: top" width=27>&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top" width=486>&nbsp;</TD></TR>
<TR>
<TD width=718>&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top" width=27>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA70><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">By: <U></U></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top" width=486>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA71><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><U>/s/ Cecilia C. Welch&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <BR></U>Cecilia C. Welch<BR></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Chief Financial Officer</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA72><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK90 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR90 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM90 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR90 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA90.2>&nbsp;</P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA74><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>EXHIBIT INDEX</B></FONT></P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA77><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB81  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 138pt; VERTICAL-ALIGN: top"><STRONG><U>Exhibit No.</U>&nbsp;&nbsp;</STRONG></TD>
<TD style="VERTICAL-ALIGN: top"><STRONG><U>Description</U></STRONG></TD></TR>
<TR>
<TD style="WIDTH: 138pt; VERTICAL-ALIGN: top">&nbsp;</TD>
<TD style="VERTICAL-ALIGN: top">&nbsp;</TD></TR>
<TR>
<TD style="WIDTH: 138pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA82><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">99.1</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA83><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">Press Release, dated </FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">November 14, 2013, issued by </FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">the Company.</FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA84><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA85.1>&nbsp;</P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML><HEAD><TITLE>ex99-1.htm</TITLE>
<!-- Created by RDG HTML Converter -->
</HEAD>
<BODY style="FONT-FAMILY: Times New Roman; MARGIN-LEFT: 10px; FONT-SIZE: 10pt; MARGIN-RIGHT: 10px">
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA73></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA72>&nbsp;</P>
<P style="TEXT-ALIGN: right; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA71><U><B>Exhibit 99.1</B></U></P>
<P style="TEXT-ALIGN: right; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt">&nbsp;&nbsp;</P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"  cellSpacing=0 cellPadding=0>

<TR>
<TD>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA78>&nbsp;<IMG src="doc1.jpg" width=218 height=65></P></TD>
<TD><FONT style="FONT-FAMILY: ; FONT-SIZE: 18pt"><FONT style="FONT-FAMILY: ; FONT-SIZE: 18pt"><B><FONT style="FONT-SIZE: 10pt">
<P style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA88><I><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 18pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 18pt">NEWS RELEASE</FONT></FONT></I><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 18pt"></FONT></P></FONT></B></FONT></FONT></TD></TR></TABLE>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA3><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt">&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA82><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P>
<P style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA83>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt">&nbsp;<FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"><B><I>BIO-key&#174; International, Inc. </I></B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B></B></FONT></FONT></P>
<P style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA10><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"><B><I>Reports Third Quarter 2013 Financial Results</I></B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B></B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA11><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B>&nbsp;</B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA90><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>Wall, NJ, November 14, 2013</B> &#8211; BIO-key International, Inc. (OTCBB: BKYI), a leader in fingerprint biometric identification technologies, Cloud-based mobile credentialing and identity verification solutions, today reported financial results for the third quarter and nine month period ended September 30, 2013.&nbsp; </FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA91><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>&nbsp;</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA92><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Three Month Comparisons</U></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA93><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA94><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Total revenue for the three months ended September 30, 2013 was $431,576,&nbsp;compared to Q3&#8217;12 revenue of $409,919, an increase of approximately 5%. Sales growth, year over year, resulted primarily from higher services revenue that was partially offset by lower license revenue. Q3&#8217;13 service revenue increased as a result of higher non-recurring service revenue for special implementations of customized software. &#8220;The Company continued to expand the size and diversity of its customer base.&#8221; Michael DePasquale, BIO-key CEO, commented &#8220;We met our primary goal, to increase revenue, during the quarter. While we remain behind plan, year to date, our pipeline of opportunities continues to grow, which is encouraging. Our work with InterDigital is proceeding forward, while new partners like AMD align with us. Lastly, due to our recent successful capital raise, BIO-key enjoys its strongest balance sheet in years, providing resources to invest in sales and marketing to drive future revenue. So, with the commercial biometrics industry starting to emerge, we are well positioned to execute and I am quiet encouraged about BIO-key&#8217;s future.&#8221; </FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA95><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA96><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Q3&#8217;13 gross margin remained stable at 76%. Operating expenses for Q3&#8217;13 increased 104%, year over year, to $1,094,308 from $537,067 in Q3&#8217;12.&nbsp; Q3&#8217;13 operating expense increases occurred largely as a result of a one-time, $300,000 reduction of Q3&#8217;12 SG&amp;A expense, after the reversal of an allowance for doubtful accounts during that period. Q3&#8217;13 operating expense also increased as a result of staffing and contract development requirements in response to higher program demand. Net loss for Q3&#8217;13 was ($782,554), or ($0.01) per diluted share, as compared to net loss of ($232,609), or $0.00 per diluted share, in Q3&#8217;12. Mr. DePasquale continued, &#8220;As we build our plan for 2014 and beyond, we feel confident that we now have the financial resources to execute that plan. BIO-key has historically focused on strategic sales development. Today, with the industry on the rise, we are focusing on tactical sales execution for 2014. We are hiring pedigreed sales executives and look forward to ramping up sales.&#8221;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA97><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK146 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR146 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM146 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR146 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA146.2>&nbsp;</P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA98><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Nine Month Comparisons</U></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA99><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA100><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Total revenue for the nine months ended September 30, 2013 was $1,658,476,&nbsp;compared to $2,353,059 for the nine months ended September 30, 2012, a decrease of 30%. The reduction in sales resulted primarily from a 47% decrease in license revenue. </FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA101><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA102><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">For the nine months ending September 30, 2013, gross margin remained stable at 81% as compared to 82% for the corresponding period in Fiscal 2012. Operating expenses for the nine months ended September 30, 2013 increased $562,010 or 23%, to $2,956,668 from $2,394,658 in Fiscal 2012.&nbsp; Higher operating expenses resulted largely from a one-time $300,000 reversal of reserves for doubtful accounts in Q3&#8217;12, as well as a one-time Q1&#8217;13 legal expense of $130,000 related to the InterDigital transaction, and higher engineering expenses related to meet new program demand. Excluding one-time expenses, SG&amp;A expense fell $49,945, or 3%, in the first nine months of 2013 from 2012 levels, while R&amp;D expense increased 25% over the same period. Net loss for the first nine months of 2013 was ($1,652,963), or ($0.02) per diluted share, as compared to a net loss of ($482,530), or ($0.01) per diluted share, for the same period in 2012. </FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA103><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA104><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><U>Liquidity and Capital Resources</U></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA105><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA106><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">The Company reported cash and cash equivalents of $225,328 at September 30, 2013 compared to $83,989 at December 31, 2012. Since the end of the quarter, BIO-key completed a private placement of equity securities resulting in gross proceeds of approximately $3.7 million. Financing transactions in 2013 included the following:</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA107><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB109  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA110><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA111><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">February 26, 2013 issuance of a $497,307 principal amount secured promissory note to DRNC Holdings, Inc. (&#8220;DRNC&#8221;);&nbsp;&nbsp;</FONT></FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt 0pt 0pt 18pt" id=PARA112><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB114  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA115><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA116><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">February 26, 2013 private placement of 9,026,935 shares of common stock to DRNC and a limited number of additional investors for gross cash proceeds of $902,693;</FONT></FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA117><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB119  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA120><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA121><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">July 23, 2013 private placement of $1,050,000 of units consisting of 3,500,006 shares of common stock and five-year warrants to purchase an additional 3,500,006 shares of common stock at an exercise price of $0.40 per share; and </FONT></FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA122><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<TABLE style="TEXT-INDENT: 0px; WIDTH: 100%; FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt" id=MTAB124  border=0 cellSpacing=0 cellPadding=0>

<TR>
<TD style="WIDTH: 18pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></TD>
<TD style="WIDTH: 18pt; VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA125><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&#9679;</FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT></FONT></P></TD>
<TD style="VERTICAL-ALIGN: top">
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-RIGHT: 0pt" id=PARA126><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">October 25, 2013 and November 8, 2013 private placement of $3,697,100 of units consisting of 24,647,337 shares of common stock and three-year warrants to purchase an additional 24,647,337 shares of common stock at an exercise price of $0.25 per share.</FONT></FONT></P></TD></TR></TABLE>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: 36pt; MARGIN: 0pt" id=PARA127><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA129><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Mr. DePasquale concluded, &#8220;BIO-key is in its strongest financial position in years. We now have positive working capital and shareholder equity to fund tactical sales development as the industry continues to ramp up. I believe we are starting to experience increased demand and we are very excited about the opportunities we see emerging.&#8221;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN: 0pt" id=PARA130><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff; MARGIN: 0pt" id=PARA131><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">In conjunction with this release, BIO-key has scheduled a conference call, which will be broadcast live over the Internet on Thursday, November 14th, 2013 at 10:00 a.m. Eastern Time. Participate live via phone by dialing 1-877-317-6789 (U.S.) 1-412-317-6789 (International) and asking for the BIO-key Call at least 10 minutes prior to the start time. Or join the call live over the Internet by logging on to the web address <B>http://www.bio-key.com</B>. A streaming audio replay of the webcast will be available shortly after the call on www.bio-key.com for a period of thirty days. You can also access the recorded call by dialing 1-877-344-7529 and using access code 10036898. International callers should dial 412-317-0088 and use the same access code.</FONT></FONT></P>
<P style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt" id=PARA132><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></P>
<DIV style="WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" id=PGBK147 >
<DIV style="TEXT-ALIGN: center; WIDTH: 100%" id=PGFTR147 >&nbsp;</DIV>
<DIV style="TEXT-ALIGN: center; WIDTH: 100%; FONT-SIZE: 10pt" id=PGNUM147 >&nbsp;</DIV>
<HR style="PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 2px; COLOR: #000000" noShade>

<DIV style="TEXT-ALIGN: left; WIDTH: 100%" id=PGHDR147 >&nbsp;</DIV></DIV>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" id=PARA147.2>&nbsp;<FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"></FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA134><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>Contacts:</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA135><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B><U>BIO-key International, Inc.</U></B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"><B></B></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA136><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>Jay Meier, VP Corporate Development</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA137><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>651-789-6116</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA138><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>Jay.meier@bio-key.com</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 10pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA139><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>&nbsp;</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA140><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>About BIO-key</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA141><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&nbsp;BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&nbsp;&nbsp;BIO-key&#8217;s technology is offered directly or by market leading partners around the world. (<B>http://www.bio-key.com</B>)</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA142><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">&nbsp;</FONT></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA143><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><B>BIO-key Safe Harbor Statement</B></FONT></FONT><FONT style="FONT-FAMILY: Times New Roman, Times, serif; FONT-SIZE: 12pt"></FONT></P>
<P style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0pt" id=PARA144><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt"><FONT style="FONT-FAMILY: Times New Roman, Times, serif; COLOR: #000000; FONT-SIZE: 10pt">Certain statements contained in this press release are &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&nbsp; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&nbsp; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&nbsp; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&nbsp; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, wider market acceptance of biometric technologies, our ability to raise additional financing, and our ability to attract and retain key personnel.&nbsp; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012 and its other filings with the Securities and Exchange Commission.&nbsp; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&nbsp; The Company undertakes no obligation to disclose any revision to these forward-looking statements whether to reflect events or circumstances after the date hereof or otherwise.</FONT></FONT></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>doc1.jpg
<TEXT>
begin 644 doc1.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0IR4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````>#A"24T#\P``
M````"```````````.$))300*```````!```X0DE-)Q````````H``0``````
M```".$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&
M```````!`#(````!`%H````&```````!`#4````!`"T````&```````!.$))
M30/X``````!P``#_____________________________`^@`````________
M_____________________P/H`````/____________________________\#
MZ`````#_____________________________`^@``#A"24T$"```````$```
M``$```)````"0``````X0DE-!!0```````0````!.$))300,``````CA````
M`0```'`````A```!4```*U````C%`!@``?_8_^``$$I&248``0(!`$@`2```
M_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3
M%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-
M#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,_\``$0@`(0!P`P$B``(1`0,1`?_=``0`!__$`3\`
M``$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`````````
M`0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q
M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87
MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4
MH;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B
M\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>W
MQ__:``P#`0`"$0,1`#\`]"ZU]8>E=$I%F?=L>Z?2H9[KK".U-+?<[^O_`#7^
MD7%V?XR>M/R7/IP\>K%GV4VE[K8_>LOK>VJO^KZ-GI_RUTOUQ^K#NO8=9QG,
MJZCB/WXUMDAI:=+J+7,:]_I6-]_T/YRMB\T-N,P1C;,VT2/7>TG%:?\`@:;/
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M'Z15K^O==Z*:KOK#BXQZ?8]M=F;@O>107';6_*HR&-=Z+GG;ZM;_`&(?1<BG
M`^MO6L#-<*LGJ%E65AO>=OK5>GZ?ITS]-V*YNS9]-3^ON74>B6](KB[J/5-N
M/B8HU>]SG`NLV?FU4M:ZQUW\VC9HEC$1Q1APW&7#ZNOJ^:7%_5>F"P?J]]:*
M,_ZLX_7>J/HZ>R]UC3OL#:V[+;,=C?5MV^Y_I)\9GURIZBRMQZ:>C5OV[YO^
MUFEHVM+M!C?:/W_\&N*^I-3*6_5UW6P7]-?4\=#<1%#,YUM[[AEM<7;\^W_O
M,L?LJV?S%/VK]*G,+Z-G]:Z3TS9^T<RC#]2?3%]C:RZ(W;!8YN[;N4V=3Z=8
M<=K,JEQS0YV(&V-)N#!OL=C0[]/Z;/>_TUQ_2J^HY/US^L+J<W%QNIU655MK
MR,=U]@PPQCJ/LSFY>+Z6/8Y^_(96S^?].R[_``:%U/ZO7=`Z&[JM%[<S(Z5U
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M`)$MIK<)!U;PYJOW8'3[OL[;L>I_V1P?BM<UOZ-S!#'T-_,V?R%G5_5=E+&M
MIR[6.8P!E@T<VQH#:LAK:RRA^S;[JKZ;J;**\?'_`)JA2;]7#7>V^K+L:^EQ
M=3/O^D=?M+GN]3)?Z?ZNRS?7^K,HJ_P2*VSW+>S^F=-ZE6,?/Q:LMC?<&7,:
M_;/YS=P]G]E!Z;T+H?27.?T_"HQ;(A]C&`/V\PZUWZ39[?WE4;]5PQNUF9:!
MKK`W;B[U/M0/_<_=^C^U_P#<?]%Z?^$4K/JPPD"K+MJJ`TJ$$-=Z9QVV5.^E
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M;]E_2?H?^$4?^:M33NKRK&DL8UT@'<6#:[U/H[J<M_Z7/I_[4O\`]&DIO=&Z
M7C=%Z3B],Q]*<2MM8=$;G'^<M</W[K7.L=_+>KTK%M^K7JW.N.98RQ\@.K`8
M:Q.YOV7;[<=[6-9C^I_A<9GZ;U+?TR/A]#KQ;VY/J;K6F0&MV5M86O9]GHJE
M_HXV^SUO3W_SK$E/_]'U5)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27
MRJDDI^JDE\JI)*?JI)?*J22G_]D`.$))300&```````'``@````!`0#_X@Q8
M24-#7U!23T9)3$4``0$```Q(3&EN;P(0``!M;G1R4D="(%A96B`'S@`"``D`
M!@`Q``!A8W-P35-&5`````!)14,@<U)'0@``````````````````]M8``0``
M``#3+4A0("``````````````````````````````````````````````````
M`````````````!%C<')T```!4````#-D97-C```!A````&QW='!T```!\```
M`!1B:W!T```"!````!1R6%E:```"&````!1G6%E:```"+````!1B6%E:```"
M0````!1D;6YD```"5````'!D;61D```"Q````(AV=65D```#3````(9V:65W
M```#U````"1L=6UI```#^````!1M96%S```$#````"1T96-H```$,`````QR
M5%)#```$/```"`QG5%)#```$/```"`QB5%)#```$/```"`QT97AT`````$-O
M<'ER:6=H="`H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0``9&5S
M8P`````````2<U)'0B!)14,V,3DV-BTR+C$``````````````!)S4D="($E%
M0S8Q.38V+3(N,0``````````````````````````````````````````````
M````````````````````6%E:(````````/-1``$````!%LQ865H@````````
M`````````````%A96B````````!OH@``./4```.06%E:(````````&*9``"W
MA0``&-I865H@````````)*````^$``"VSV1E<V,`````````%DE%0R!H='1P
M.B\O=W=W+FEE8RYC:```````````````%DE%0R!H='1P.B\O=W=W+FEE8RYC
M:```````````````````````````````````````````````````````````
M``!D97-C`````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92`M('-21T(``````````````"Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````````````````````
M````9&5S8P`````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0``````````````+%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````````````````````````
M`````'9I97<``````!.D_@`47RX`$,\4``/MS``$$PL``UR>`````5A96B``
M`````$P)5@!0````5Q_G;65A<P`````````!````````````````````````
M`H\````"<VEG(`````!#4E0@8W5R=@````````0`````!0`*``\`%``9`!X`
M(P`H`"T`,@`W`#L`0`!%`$H`3P!4`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0
M`)4`F@"?`*0`J0"N`+(`MP"\`,$`Q@#+`-``U0#;`.``Y0#K`/``]@#[`0$!
M!P$-`1,!&0$?`24!*P$R`3@!/@%%`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:
M`:$!J0&Q`;D!P0')`=$!V0'A`>D!\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"
M70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#
M`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$
M8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F
M!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'
M*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2
M".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*
MQ0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9
M#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/
M00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')
M$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4
MK13.%/`5$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6%OH7'1=!%V47B1>N
M%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;
M%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4
M'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B
M@B*O(MTC"B,X(V8CE"/"(_`D'R1-)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:'
M)K<FZ"<8)TDG>B>K)]PH#2@_*'$HHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K
M`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1
M+\<O_C`U,&PPI##;,1(Q2C&",;HQ\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4T
MGC38-1,U336'-<(U_38W-G(VKC;I-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\
M.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_
M83^B/^)`(T!D0*9`YT$I06I!K$'N0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42
M155%FD7>1B)&9T:K1O!'-4=[1\!(!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+
M4TN:2^),*DQR3+I-`DU*39--W$XE3FY.MT\`3TE/DT_=4"=0<5"[40914%&;
M4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755PE8/5EQ6J5;W5T17DE?@6"]8
M?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A
M7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)F
MZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK
M;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X=!1T<'3,=2AUA77A=CYV
MFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["
M?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'
MGX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!N
MD-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9
M_)IHFM6;0INOG!R<B9SWG62=TIY`GJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-V
MH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42M
MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+LL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@
MN%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"
MV\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*.,JWRS;+MLPUS+7--<VU
MSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9
M;-GQVG;:^]N`W`7<BMT0W9;>'-ZBWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\
MY83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q
M<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ
M_DO^W/]M____[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#
M`P,#`0$!`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P/_P``1"`!!`-H#`1$``A$!`Q$!_]T`
M!``<_\0!H@````8"`P$`````````````!P@&!00)`PH"`0`+`0``!@,!`0$`
M```````````&!00#!P((`0D`"@L0``(!`P0!`P,"`P,#`@8)=0$"`P01!1(&
M(0<3(@`(,11!,B,5"5%"%F$D,Q=2<8$88I$E0Z&Q\"8T<@H9P=$U)^%3-H+Q
MDJ)$5'-%1C='8RA55E<:LL+2XO)D@W23A&6CL\/3XRDX9O-U*CDZ2$E*6%E:
M9VAI:G9W>'EZA8:'B(F*E)66EYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35
MUM?8V=KDY>;GZ.GJ]/7V]_CY^A$``@$#`@0$`P4$!`0&!@5M`0(#$00A$@4Q
M!@`B$T%1!S)A%'$(0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U
M&50V160G"G.#DT9TPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U
M*$=79CAVAI:FML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FY
MR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1`Q$`/P#?V)M_A[:8DR!1PI_E
MZ\2%%3PZASRNFN569@J(@B,D,43LSD%A(5,@D"_U(6W^Q]ODK&NIS@?Y/V#K
M:5D'Z0U']O\`@Z(M\L_YCWP]^%55@L=\@.Z\3M3<>X6*879.&ILEO3>60I?%
M*7KZG:VTJ'.9W%XY6B<1UE4M'3RR1LBR$HWL.;ES/86+!'D0-JX56OG_`$AC
M]G0SY6]MN:N;YWDVZPG,6@J"$D\,FHI33&Q+9`JM:`BHX=!_TA_-P_E__(.N
MQM!US\DML+7Y@TE)C:/>U#N;K26NKI)?"U!0CL+#8"FKLB:FZ>*F>H9Q;3(Q
M]*H+GG':PMJ$N4U,RU`(KFN/BI^7#Y]"+=O93W(V;;;FXN>5[LP(6_4$<G`)
M74"8U:E`3D5P>T>=EE%()8BXG$X=@X=3J0*\<;JJ,&<,NE@002.?8MBN([J&
M&:,``H#Y<2*YI7.>%3]IZBQTDCT12IID44."*D8)SGC_`*J]2_=^J=8)+AKJ
M7OIMI!.GZDW('Y]UDKX+TP<Y\^'6EC5I0YE(('"N./&G\NFG-9?&X'%UV;SF
M4H<-A\72R9#)93*9"'&8W'45(CS5=775]4\5-34T$*ZG:1@@4$D@<^T\#E(I
M'D;`!R?L'KTZMO/>31VEE&SW#-0!022>%`%!)-?*G11X?YAWP,?7YOF]\2H0
M)9442_)'J"*;T.4.N-]X1M&4<,I!%P5YY]E\.\V27+137*Z\T&H4I6F03Q_+
MAT*K?VW]PV=3:\G[E<(R`@K:W$@-:$4*QZ3BE*>O2DVI\WOAWO\`W#3[4V#\
MM/C3O;<E4@-)@]I=\=9;FS4PD=HXRN'PVZZFME$K1E48*;N"`.#[4S;EMQEB
M'UB@DC`=1_EZ2OR5S_!/-!?<A;PB`,2197*T`-*U:.@\\\/V=&'GS=#CJ>3(
MY#)4U)C:=9I)Z^KR$<&/IJ6GHYLA/6U5742)#%3I2PEB[.55/42%N?9C)X0T
MS)*#$$%<C!XY\JTI6O0:6VN)$2VMK6Y%P;C3212')X44"I*:L#&6J*5'0:=2
M_(3I'OF+,572_<G6O;5+@*BAI=RS]:]@;:WM3[<JLFM0U!1Y.HVS7Y&&@KJE
MZ60""9XY@H#%`"+Z6[MIETPLI:G$4P3BASQZ-=TVS=MD%E^\-KDB615(+QNN
MH&O<-0%5-./^ST+515^$2ZIS"8X4=WDO$41XV(D7RF9$8&-C=TT7!!-P;558
MM+++<4D.0-0!I]A\J^G[.BN)YIYA;Q6Q+G([33)H`2*GB?3AT2/LK^9=\%.F
M\S5[=['^6G2.W\SC&%/D\5/OG#9'+T%6LDD<E+D:;"5-6M#6(8_5"ZI(MP2H
M5E)*FW;;;24B2_!7YL#FO[/+H:P>V/N=>/&]MRK)],U*$PS"M?.K``"A!S_@
MZ5_2_P`\?AY\B,N<)TI\E>HM^[A15D7;.)W[A),_40R6$=53;?GKH<O50.Q*
M@I&RW5A^H&SHYAVR5EB@E1R?,4KQX<1\NJ[Y[=>X.P0AK[EF14\/Q"XBD<*M
M&K4H"%II).JE!DD`]&VI9'FB)=VO%+H#QF8)*-"2"0^9>4;R?V6=;#AOJ`:1
M2K("5`S\N@$(KB6GC%HY5/`54&GR.2"<?EU-B%@_J=M4C-ZS>U[<)_2,?CW9
MS4K@#'E_E^?2K67`!2A44X4K3S^=?7H"^]/DU\=/C1C,5GOD9W]TOT'@LW4M
M1;;RG<7:^Q^K*'<66IXIJJIQ.+K-\9O!461JDIXD;QPR._J-P.+TZ]T,V'R5
M!F,?397%5M+D\7D(8:W&9.@JHZ['9+'5<$530U^.KX)ZFFKJ*KI94>.6)S&X
M-Q[]U[IS]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_
MT-[KLO?FUNK=E[H[&W[FZ;;FQ-D[?R.Z=V9^MDF2FPF%P%/+DJZN=:6-JJH7
M[>%M48OJ"V"M<JZ:ZD%O$]R3A1_@STHL[&?=+R#;K="T\K`*!YDF@]?7TZT]
M/GO_`,*-=[=AG.]2?RZL)5X_'M2"DR?R*W900C+U]%4O64\M3UUMR<C$;>C@
MB(,>9S,3)*[NE/''/`6]Q+O_`#^(FDMH9*-5E.<^8QWX_+/V8KF/[3_=IO+X
MV>Z;[#XEI5'"Z7"T_2<ZM5N0XTDBA.DBM0?+7&_@>8W%NC);W[2W1N3L+?F?
MJY,MN7<^Y,CE,[5YK+3GR25E;D\[4UV1R<X%E\L\C$!0L=HEC41)OV\W5PHN
M%D;TXG^D?XCZ^O6>_)?(O*_+44,5I8PFZUC&B(U-$'!8U/%1_P`7TN]1C"MY
M_#!.-.D?N0M-C:BAK<9')2\I(WD:;3<$CFWLB@W.[GNK%#(U=:>;>OV]#/=;
M6VW"#<=NW'8XA9?3R&O@@"E"M:L"OPD^7\NOH4_RD]Q]C;K_`)??QYS7:E5D
M:W=TF#W#0"MRIJ6KZ[;&%WAG\-L;(U$M8SU$[939=!050D9CK$P-^?>7O+`8
M;#MA8U<Q*3^P?Y*=<7_>^VVRT]S>:;;:8U6RCN&4!=(%0S!L)110BE`!PSGJ
MQ[V?=1-U@E=U8:0&N`"+$FUS<V!^GNX571@33JR+$7.IZ24X5'#HNORSRT>"
M^,7R,S4JJ8\1T-VWEYM0%G6@Z\W16F-@1ZE`ISP?Z^RS='^FVZ[91PC;_CC?
M9Z="'D92W.NP1!=2F]@Q2M:W$8IUJB?\)_OY<'P[^7OQ&[;[/^1G26$[$W'C
M?D7N;K_`Y.KS6[<34XW!XC8W6>ZEHJ>GV_G<50)&^2WG42M)XS-)Y&#L55`H
M&Y3VR'?%O=QN&):.Z>.E?)0C^A_B(X_D./647OWSKS1R)S+R39<O[I+8PR[!
M:2E(V>,,[RW"ZRBLJDD1J*T).D`D@`=#?_.@_E(?`OH#X3;[^1?277\/3'8O
M4.9V!D<14XS>F[WQ&Y8]P;\Q&U*W"93%Y;.5\,%>*3*S3XVO@5:NFJH`RM9+
MA;O>TV=M+K%QHI0@:LGN(IGY5./0]$'M+[E\Y\W<YQ['O4T]Y;SHRL[:OTQK
M0:^)4ABVG*\7!KQ5K0/Y7?<N_NR_Y.W5/:7;V3J\WN^@Z3[AQ>2RN;D:HS&;
MV_UON/L':.T,IG*BHU39'(Y?8^UJ"HGJ9B\M6\S32,S2,2:I.D'+4CQ3%_B%
M:UH0AQ4<,4-.H\YIV][7WP:RBC)LOWNF&!H6-T`U*`*1Q'"OD>JP_P#A*WB:
M.GZD^66Y%AGBJ\OV;U_BZJI8NM'4Q8C;5;E*-492%:J@K-S2O,3R5F2]P?:/
ME=WE@NYG8D!P<U\A6G\^AW]YE+>S7D*WM+5$=K"(-10,MJ`^&AK5?,=)K^9-
M\I/D9_,-^<]'_*D^&N^LMUQL#:.2K<-\A=_82O&/AW#D\%'2YG?%%D<G1$Y+
M%;.V+A'>A-/&[4^5S%;#3R*?`BJ7[O=3W^ZQV\,Y6,)0BNG@S5\SY>7\NE/(
MO*^Q<D<AGGGF>V_W<EU,0901X;0QR1$(Z*VII`065J<:,!J(L\^/G\@O^7)T
MQM"BPVYNH&[KWBD3#-[V['S.6R$^1K*FIER56]!MK%Y#&;:V_0"NJI1#%!2K
M)%#IB,CHB6$%KRS82P@W#:R0#4G/`>5.&?F>HXWSWZYRW2[:#9KOZ*UC)4+%
M48!(!9M;&H!'#2*`8Q7H"OFY_P`)]_BQV=L;.;E^)6"'QI^0.UZ6?<.P\I@L
MQN>LV%D=RP02-B*'-8*>OJ)]OS5U?3PH*W!RT<]*%U.)$;2R#<.6H;<_46-0
MJCAY5&3P`^7G]M*@]'?)OOCOL%RNT\WM%?;?/+1I90TKQJ^E-(+R!:`:CHTX
MU%A6I5FK^0C_`##NU/D;MKLKXD_)?(96L[T^-N/HA0YS,5D\VYMR[)IYCLVO
MH=S9&6;7G=U[&W%2&FKJO299?N(&E)F5V?>S;J7D6S9N]2!^0(!\ZD\*8]?E
MT8^^'(=CL]AMW.^RQJME>JKNHI0/*DDRD*B!5!5:,`YJ=/$DL=D*C9FBN[^1
M@P#'3I`8(FH*/I8-?_6/'X]C1P1HJ,E1UCIJ+QP.RT9D!/YYZTI?^%K,FCXV
M?!P4[)-DV[\W^V/QJ`FLKBFQ*#4U*JWD+Q5;4Z>D:AYB/S[IUKK;G[3[6ZL^
M)72>=[)[3W=CMC=2]2;1@J\[NG<-2[04F$P-$E/#1P0QEZZNS58L(C@BBC=I
M#H158\>_=>Z`/X/_`,Q+XV_S&MB[B[0^)N>WQNOKK:N?AP57O3=G6^_NO,3F
MLX%CK*_";6&^=NX4;F3$4U2L>2GI"\6->HI=3,7`7W7NB^_-_P#G9_R\_P"7
MSN>GZT^07R`5.X:J*DG'3/6VU\OV=V1B:>LFGJ,=%N*CVC2;DQNU*VIQXC9H
M\M515%1`T<\4:+/&Q]U[H,_C'_PH._E@_*OM:AZ0VAWQFNL^R<S74E-MW:O?
MVR-Q=.S;MJI_#,N*VSG-SPC%G,3/,J)CZNIBK*S4%ID*FX]U[HS_`,A?YIWP
MW^*ORIZ8^&7>G9.Z=H=X_(-MH2=5T,G7>\ZW;&X!OC>YV'@:)M]8S"R[-I*B
M;=&/GHYPU3')1II:4*9!))[KW5BU/4R&-))`JWFD6?\`>698]$4SSQQLB1W^
MVK(VBY%RJ7_I[]U[JN?M?^:G\-^GOF9US_+]W5V5GZCY3]J?W8&V.O\`:W7F
M\=XI!-O"3(_PL9W<6!HY\'M^/&X^A.2K5JIHF@QH$[G0XM[KW1A.W?F!TCT;
MN"7;?9N4WYA,A2=;;W[AR,^+Z;[JW9M_'==]81[6D["W'7[LV?USF]LTE+M(
M;SQ+5,$M;%56KDU1!6%_=>Z?-H_)[I+>G86S.I=I[YBS6_M\='X_Y(;0P$&.
MW0PR_1F2S6/VYB=^#-5>"7'"/(5>8I?\CJ:A<BCS(98D5U=O=>Z'CSQ_\=?]
MV:?^!D/_``/_`.=?^K_.?[1]/\/?NO=?_]'?&WGMK![TPF<VCN+#46>P.XL'
M6X?<.'RE)#68S,X/*PU&/R&&KJ6H`@JZ?(T$\\95SH0D%AR+I+JWDN`5R82M
M",T/'RX<.E%K<3;?<6NXV\[1SI*NE@:$$'56OR^WKYHW\P/XB;@_ER_-3L#J
MJKI9Y>J-V25^[^G<Q6TSU;[@V!N#.2K@XFS4Z>0938V0>IQU<FJYCI(I?TR*
M3CA[@<L727KR6\905K5017,A\E^SSXCY==4ON^^X+[[RG90QWD+3*JHPD<DA
MEBMU(/>3Q-1@5!K3(Z26Q=F;T[-W71[*Z^V_F-X;IR<M5!2X/"X^6OR%5-!*
M]'45M1,)JFEH\=!'`)9:^KI?M:6$AI)XU%U!MCMEQX)6X+/1N#5/`#U'V]9%
M7V[;3L5G^\MQO+=-U"ZDC1T`9:%E;2Q5RQ=2M0:'`&>A)W'N/XZ?%:HCQF[G
MP7R?^0%`*:&CZQV;N"LDZ-ZPW!'+4/%5]P=FX&:HJ>U<ECZF0HV*VG,V+0KX
MJK)2,9:6D$%M%MUF0TEK"95_HK@@C-?,X)%#3@:G(ZAW</<CFOG*Y?;-JL+B
MWLW(3Q1%*CNC5!X2MH'ZBZM::JJX\->QRL]H_P`R7^9?2Y>BSC_*OL/8V/QE
M-0XO;?6^R\3M/:77&!VSBJ2GIL+BL3UY!MU]K4=!CJ5!30?:M4Q-2PQ!Y6F6
M55,KCFR^!2TM=RGC`04"2,H`R``%>@`Q0`8Z*[?[N^RWUK/<[OL=I+=W$QE>
M:6%'E[P"VJ62W9R:DL=18ZB6+$UZMQ^%W\]SY!;7[1VQM/Y99ZE[+ZPW1E,1
M@,MO!\%@-M[MV#49W,8;$XW.R4NU,;AZ#,;<A1:J2=I$:="KEFTZ`#SECGRX
M@W*&SW._DE#,!W-4Y95_$X^?$&M3U$WNC]TG9+;EG<-[Y6G$=W#&\A59"R]D
M4LC#2EN2*T4"C*!C\]Q>BF^X@^Y61W2=EDA+:.(6BC*B-D+:XG-W!)/ZOZ6]
MS^\B20Q/%324!P>-:FI^="!CTZYT`,'NXY(M,L+O'D4)T&E37)J?/'V#HK_S
MER%+B?A9\NLOD(EJ*'&_&;O>MJ8=&MI(:7JS=LTR,#<-&T8((((L3?CV5;MG
M:[K5D>$W_'3T-/;Q*\]\G:0,[A:U^?Z\9-?]7'K4._DQS_S<,!\3]S-\$L!\
M7\ITUN'O'=V6S=?W17YFFWA2[^CV;U]@<O2XV*@R=-3/A4P>%QDD1>(L:N6>
M['@`!<MS[_!M]]%LMG`T#7SU9E>NHJ@(!4A>`4Y%:^=.LJO>RY]I7YLV!/<.
M_P!P7>4VN`1")X/#%N)IQ&*2U<$/XHHG:%IIS7IM_F787^:$\/6F\_YKF#W/
MN;X-[1WQC:_?^'^*N5V#C,1BZNM-=3XW)Y>GJTJLD]8)W6"#(Y4R4E`TL2T8
MBR$ZS#6]IO0DLKC=E3PPZU"U`I4D@U%.%>-?\/5?;R\]N%N=SB]N0?WP]JRI
M),%:0,2@2FAA)37X;$)IJ>!J%IM);5W_`-`[E_EB9O?WQM3'+T5C?B;OR79-
M#2TM53''8;;'6>:HZK#9FBR1DR<&X,35XR>FR:UA:K:N29IV>1G=A;*UI)L4
MIM4`M_I&-`!35H-30?B\JG/SZQWN+'F2'W=VZSW^63][2\Q0,6J]71[L4;N&
MHJU:C%*4QB@J5_X2WT\C?#+ORM:(+32?(W,P0S:0&>ICZKZQF>,,.?V()(BO
M/IXM[+.3"TNU;L`>[Q7`/F*(E*>E"?+J1OO(R"#F;E"QG;4RV$%`<T/BSK6A
M_P!+Z=%>_P"$Z8I=]?-K^8=VGO(1TW:%5"L7V54RBNCAWMVON?,[]D6>8&H!
MH]PX"A,MC=I"K-=@""O8K=WN+R2XU,XN'%3DZ:KC(X<<<.A/[^/=VOMKR1M5
MG`@@DLK*4R!3J!-M<*5UK0`4`.FA-<UIUN1J@6.S1DDD!M*WU$J"SF_).K\^
MY#6X$<=!'@<*#Y?;UAX@\!(2(QXI`U$#-?,GSSYU_/J/.B%E`7UL-+DV!$3%
M0Y'Y+,RH#^+6_I[O;-XXGN&!$04KI/`D9J5X<"17CY=78>$T<X!-7&.-#QJ!
MZCA7K2[^*78.Q^G/Y_?\P?MRIS%%A>G>M=K_`"M[$[BW(*2IEH=K;0VM/M'<
M786YJRGQ,4M54"FW31!:BT+L[P@V:2P]Q[L<T?\`6K<E91H+2Z<8!\4`4]/E
M3AUF?[CQ->>P')+R+ID$=B*'M)`L'/G6OF?G3&>KF(?^%%O\EN-G7_9].O5C
M+S-*\FS.YHX83(RNK*7ZU.LM(2@`ETJ!8<>Y"A+DS:B320TK4X\N/E_+TZPN
M6-X]:NQ/<:<>'D!7R'E3'IU0=_PJL[2ZR^1G7G\FOLKJ/=-%O/8_=/;&^]Y=
M>9F-\Q1G<>V-RTG2-31YO'4N1@@K5I):*O$,:^-#!/51Z=);V]U?IDW+V5V;
M_P`*HOFIE>B]B[RS?2W\IKXE;APVZNTZ>3)Y'!]L]Y96LK\C3[;?+;*DEIIW
MK]WY7$U--B(:VFFAVE!3U$Z`ULL-/4^Z]UM7_*C>_7_\LO\`EI=\[YZ.V5MW
M96S?BC\<]X9#J79.*Q,`P&+W+M_!2IL/'UF-C0)4KD]ZUU'+65#B6:K>2:KF
MEDEG>1O=>ZT3OY$?\R;^7_\`#&'M+Y5_,3JOY6]\_.7NCL+/98]V87I;&]KX
MS:FQY9*))J7;N^=X[PQF=BWAD=RIE_XQ74^J2IA,$4DTAC,<?NO=#Q_/L_FK
M_P`O7^:!\8\'0=+]`_+#"?+#JK?FU]Y=5=K;NZ$H-MU>#VY1944&ZL)+N;`[
MYRN=DPT]%F9<C3T.EH174*5!57C#>_=>Z&_^=UU1VQ\@_P"21_*B_F>,^6@^
M3?Q@V3T'ENT-YP19&+-T>'[.V;M"'*[AW"9C)EER&W^]-G[?:TTK244^2K)A
MI>:0M[KW6WM\:_FAUYW9\!>H?G5ELYB]O]>[K^-V$[WWY-YE.-V738W:+YKM
MG&/5QO/_`)7LS)4V1I!"MO'-CS%Z`Q]^Z]UJX_\`"<'K'=OS_P#G_P#.?^>'
MW7@JKQ[G[$W;U?\`'&',13.^V*G<U%2#<^.P<N2$TLE-UCU)+B-KQ5<,B^B>
MNA0E3(A]U[K;7[R^--!W=F4S=7N_);<J_P#9>N_/CM5)C\/@<E#/M[Y$Y_I7
M([QRX;+PRR&MQ=)TL((H&!IIADGE=6E@A*^Z]T&W0_PAV/\`'SLW%]CX#>.?
MSE7B,!WALZAH,W3T4HQVP>S\QT17;.V'C):..):3:G5&T_COB\;B*8+H05-5
M*%1ZJ4-[KW1X/LE_K5_YG[3_`($GZ?\`*_\`]1W_`#=_7[]U[K__TM^V6!'E
M:9PI_P`FD@!8`D"1@S@7!LKZ!?GFP_I[OXBI&`1^+_)U9QXMNUN.)-?Y4_R]
M$/\`G-\1/B]\G.NZJO\`D%\>H^_*WJ[:F^=T[)V[A\CG=M[UKZI<.9LEMO:^
MX=J9O;F6BJ-U5$%-3M!-5I3/,T4MM<6I2'?ML@N[.6>2$-I4FGGP8^A]>AGR
M3S+S+L.X6&W[5S-+9>+*BU$SJ!4HH8C4H[0H\LT`.*4^?/V3\N-V=E#=_1_Q
MNVG3_$?X_/4U,>XME[1R.X\CVEOC`BLK:>*G[A[0W7E*[?&]5C8O3-A6K'PU
M&8"(:=)7G9\>MQN4M9YK94`6K<!QS3.<_",<!Q`!ZZ4\I<JW6_0[1O6_\PR7
MD[10E-4YE5%T@@*KH0II+("P[F5]+,PI0)=M[1PNU(*./%TBI4T9D>#)244E
M)7*T\:1RO3-4%IZ2.6.-5*Q,L9L>/K[#\\GB$Z>LD=EVC9MLM8S#81F4`=VA
M*U`7-0H/$5Z48CC4:5154$FRJ``68NW`%O4Q)/\`4F_LCF$D%T+ACC13S]:_
MZL]';W\DT#6E-,;FE>%*C3QK04'RZ%'I?IG???O9VS>I.ML)ELON??.=QVV:
M;^'8Z2HH<;3YBH6&LS&;R4:%<)B<=2PL9Y69$E1M#7`M[,.7MJN=WWNUGC)H
M)%]?*13Z'^+UZC+W2YCVCD;DO=VO[X,T]O*`&=#\<$N*,T9_T,B@K^?E]-3;
M=",9M[$8[4'>@H:6AF<*R*]30P)1U+I&ZJ41YX&(%@#>_P"?>8%I`UO8P0L:
ME44?L4#KBINUW%?[ENU["FF.:>5P,?B=FR1Q.<GSZ)+_`#/]P#;7\O+YJY$3
MTD33_&;N7!LM0\D1MN;8N;VZDOEA<2+XWR9T&W!)Y]IMV--LN<_Z&W_'3T)?
M;A5;GOD^HK2^M3_U7CX_ZN-.JB/^$]O>_P`:NJ/Y>>.V_P!B=Z=.=;[RR'<_
M9^?RNW]W]K;-VQE?\JFP=%25\5!NG,T.1:AGH\9&J2HAA+QNH;4K`!/DZ]LK
M>ROX[G=HX'^M<Z&E5*C2F=).0:$5\Z4\NIP^\7ROS#O?/&P76S\EWFXPC:((
MS-%:2SHK?47)T&1$8!E#*Y6M0&#4R.E;_.^_F3_$>A^%7:G1NRNW>O.W>R>Y
M,'B]LX#;_7>Y\/OVBQ%+4;BHFK-V;IR.SZW*1T--BX\83!`'%1/-8:"C!E5\
MX[A:-8)%;WD<K2:::7#4^(^1/&G`>M?2J#V6]KN;[3FNWWS=]HN=NLK35*3-
M#+#J`*`@:T73I5BQ)Q1:#\15-_"+KWL3X_?\)U^]J3LO'Y;;&XL]\;OF'OG$
MX3(Q38[*8/"[SV?OV7;1>$^.6D?)1A<E$``R)6+>S7][VB%TY4W"2448PR$?
M9X0]>O<T;I9;W]X;E%;.Z$T=KN%I"[!@RZTW!F8`@D&FL`\"#4$`CJ5_PEX6
M/_9`NX(=,:&+YB[^IY7*K=D'2O0D21AC_1I+`'CDC\^V_;P^)M^[+0D_42#_
M`(S'TE^]B?`Y_P"7IE-$2PA/[+B[X?RZKG[JI.QOY(7\V#=OR<FVAFL[\,/D
M]D-V5N:KL+3UGVM-M_?.;QNXMP[2Q5/1`(N\MD[PG:NH(6%.9L?*8T?26`27
M5Q^Z=V:(?V;$MZ`ZF(/IF@ZD/9KK;/>?VT@V1[Y$Y@M+=$1=::J00*L;!:S2
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M.3H720%(K55M4A_DQ_RG?$)5_EW?$F`B0^N'H[9,D\J(=$:S:\$\LB/&BLRF
MX+L2;DEB,&0(:#TZQY9M1H34K@_:./6L[_PIWV3M;97RC_D)?'_J#8^&V5M;
M:?;6]=M['VEM#&4FW=J;9V]G^U_B%AL%MO#X2BC@IL-CJ.'9\L44-/'%!'"=
M**+$>Z]5Z$W^;]\,NZ_Y3GRPQ_\`/$_EQ8>K.UJS<L(^='Q[P\%4VWMQX',Y
MFGI]S[KEP^.CJ*>7;'8M9)#CLM,D+S[>R\\&:IXRTE944ONO=72]B]H=9?SM
M?Y-/?.0^*>?J,Q-\D/CKV7M_:F$K*F.DW#L[N;'[9JLEA^KM^^&HDDPV2HM[
M4E/25#W,%10.)(Y)89XY)O=>ZI*_X2S?S/\`H/K_`.,=1_+C^1.]-L]"?(#J
M/M3LF;96#[-S&*Z]QG8>&WGN.;<6:P%#D,Z:2"+L+:.[*_*4TF(41U$M+'2S
M+J\Y">Z]UM?=H_,CXD=._P`-3MGY)=&["J\[E,1AMOT.YNT]I4>=SN;R]5%B
M\/B\/M^+-C.9>NKJRJ\:4U)!()=9Y&I@/=>ZE_+#X_;0^7OQC[Y^-&\W@DPG
M=G5&\NNY*N>C>0X2LW%BWI,+N6&GJ8)'I,MM?<BTF1HY/5/3U%)'-$RN%*^Z
M]U\S[8'\P;N[K_\`E&]K_P`BW$TF5F^7&Z_G1FOCC@=JT^+JH9\3TSO7<G\5
M[!VC1&'0M#6YGY$T<M#I2,*V+W%,[#2CW]U[KZ0O\O+X:;,^!_PQZ!^*>V8Z
M3)IU1L:GH-R[B:FIC-N[?^X#-GNR=VU+B%))'W)N_+5TB^34ZTICB+%4'OW7
MNCL,B.I1T5T)!*LH920VH$J002&%_P#7]^Z]UWI7_4CZ,/H/HQNP_P!9B.?Z
M^_=>ZZT)_J5_3H_2/T?ZGZ?I_P`/I[]U[K__T]_1^;I_52?]['O8`.2*BO6G
M5C&Q1B&^7316PM)%*D;1QSI!4-%+-$DD=-(\,D*5C*[Q>1(%9@R`C4'L2!S[
MNVEJ*0"M.!R/V<.FK%@MTKW"ZV4CCDX(X$Y'GD9%>M`C^?A\(9_B!\M:#Y&=
M=8B2BZ4^26<J=RUU/24@FPFT^X*!&EW5MVOI(E-)3XK?5/.N4HRRJ!5RR@"\
M=_<'>Y6SK%N$=U862+`;?.A0.\-(23I'&E,G)%/3KHE]VWG^SOMF_=.[;L[[
MM'=J%5WP(BD"1A=;UIJ##2@HIK0`$5J\AK$K:!,I0RF2BJ$%9!62NU?XX2?%
M;(N"]74*T405"FI_("!]/<*(;V>Y,"0O4-3`;UIUGW'=;?8[.E]?3PI;>&&U
M%E&-&KBQ`X`GC_+JVSX/_P`I#Y&?+]\+O+.TK]*]%/.*D[YW5B99=Q[GQ[I2
MZJ?8^W6\$U4S-/>.MS3P4H+$)YVC>-1[L/(E]NMQ!<W186P(!5M5"*J?A9""
M2"1Q`/#K&CW8^\GRGR;9W6S;.T5UN#HSJZ&)V1V$L8!DCN`R*A16-$9EJ&`-
M0.MQ'X@?!CX[_#;:ZX?J+:%+#N&KIHX=T[_S<%!D.P=TU"QTFK^-YU<?02TM
M`C4R218VCBI,;!(6FC@$LTLLD^[1RQM.TP1"UL(TFTBK!$#'`R2%!X@?L]>N
M:?/ONIS1SY?7";OOES-:&;4L)FD>*,5<*JJTCCM#M0\:,0*+0`Y\(4`JJ@(K
M:$32`J(JJH55'```]GPC"+IU5'^#Y=1\4"``>8KT&'=/3NP>_.L]X]/=I8*;
M<W7>_L--@MV;=AS&:P2YC%3,&J*"7([=K\3E8(:G2H?QU,>M18\7OXI%(ICF
MC#1GR(!'[#CATOVO<9MMO+>]MI-%U$X96X%2""I4@@J5(J"M"/7JJR#^0/\`
MRH`9+_%JHA7R&T*=Z_)*(QAPLKK+K[CD\DKR.SEE(5M7T)NQ02[#LLK:X]FM
MJ_Z0`U_+B?GT/)?>GGRQ$=K'S5?-V@U\35G(%"6!6@`QZY\^ADZ@_DX?RTNC
M-PTV[>O_`(G[(_C5#5QUU#6;TRN]NVA19&/Q^*LHZ+M#<F\Z6CJ(O&I1XPFA
MO4H!))3R;%8,5!V^"@X`J#2G"E0>D%Q[O>X%[#+&_-FYZ7!5J3RK52*$'3)2
MF>%/\G1]NSNJ-D=N]:[PZFWW@8L]U_OK:V6V?N7;`JLAB*?*8#+8YL;5XC[K
M"5>,KZ*CJ*&1X66&:*\;LM[$^S"&VCC@:W=%,3`]M.VA`%*<*4%*<*=!&RW2
MZMMPAW.*>2/<%E$@E!*R:P^O6'KJUZNX,#JU"M:CH)/BK\-?CQ\+NO,KU7\;
M^NGZZV)G]YU?8F9P55N[?>^GJ]YY##;;P-;FI,OV)N?=^9CEDQFTL?&(HJE*
M9&I_(D8D>1W?M;:SL49;*VCA#$DZ%"U)%"3II4F@KZ]+M]WW<>9)UNM^W&:]
MN%4*K3NTK!068*"Y8@`LQ`KQ)/F>AG[(ZQZ^[:VCE]@]G;*VKV!LG/4GVN8V
MIN_"8[.X/(P^NPJ:#(TU33NREKJV@LC<J0>?:"[VJVO9!+)"I;AD#U)XT)XG
MI)L^[[OL=XEYLFX2VLH%-43M&U*@TJA';@8X5`]!U3GOG_A/9_*^W=75^3I>
MG-P]=-D9TGK*?8':N]\3CG*N6C@@Q&6R62PU!1QK94@IX8XXP/2H)))=+RS%
M)A11?0?]$]25#[O<U0PJMRBWTPSJF$LC$TXD^-D\<T'$^O1@OCI_)P_EV_&;
M<E-O?KSXZ[<S>]:">GK,?O#LZMSG:62QM?2H@I\KAZ#=E3D<!B<W#H!2MI*:
M&KCL-+@!0'K/8+&S1EFM(7DU5#%%8@8Q4J#Q%?MZ)]Y]V.>=YN$FBWR\V^-;
M<0&*VFN((R@+&A03,#4-I/D0JK3MZM#AI:=8Q']O'H5D9`\:&^E4*.$T@1:"
M+*H`TVX`]G2]HHN!\NHXD`FD668!Y0:ACD@UK4$YK4D_;U($40(81QA@+!@B
MW`N38&UP+GWLDG).>M^OSZ(K\F_Y;GPQ^87<?2_>OR+Z=?L#M3X\5F+RO2V[
MF[$[6VFFQ\MC=P?WFI*NDP>R]_;<VUEZM<[3P5)-;05#NU/$'=ECB6/77NC<
M[IVMM_=FW=S;6W9C,7G-K;LP>3V]N[#YNC2JP>9P6;HJC&9C$9#%3%34XS*4
M57+&\;2&-O+(>2S:O=>Z)9\+/Y9GPK_EYS]@K\.^JLQU!1=C&A.^,3!W!W5O
M?;F3K,:*D4&4I=K]A[]W9M+"9^`U!@$E%3T\D-&D<0T1$1^_=>Z`SYG_`,B[
M^6%\\]WU_9'R"^-.$/9N5DADS'9?6V;W1U9O/<54%EUUF[ZK8^4Q6+WAE95F
M"R9#(TU55RQQQ1-*4IXE7W7NBQ=+_P#"8[^4!T/V+MSL?&=&;[WGN?:.>P6]
MMI#?_<_:F:Q&`SNS,MC<QAZ^##8#.X##YJ#&U5)&?LLM35]-4>4J4?D+[KW5
M[F\=Y[0V%M;<.]=];CQFW]H[7QF6S6XMP9>MBI,=BL+@J&LKLW49222H2&6"
MAHJ6MED"(;1P$*ODC4'W7NM$W^2WTAL/^:1_/6^:7\UK#]>4>`^-'3':6:W-
MTZ9,;4+3;S[NW+3#;.Q]V97&Y>*6FBW(-@XW*[QRB06&-S^<QDJ$3QQN/=>Z
MWZ(=`0B/3H#N`5_M.&(E+G\R&;5J/U)^O/OW7NLWOW7NO>_=>Z][]U[K_]3?
MRETWM<ARO!!`_/\`M_=@"5-.'5'G6,Z#Q/\`Q72/W#CLW4P.,1F7H*HH?'J#
MO<DM9@ZG@'^G^'O7V],:6)UKU63\V/@YO?YB]3Y/IKL/<M!D-DYNMQ]5!'#2
M@Y+!9K%35<]%G,=5R*ST-3$M:RQR1%9$)>Q&HW+]QL+*^MI([A`9""!4*<4/
MJ#YGH8<J<TWO*M['N-M<LLJ.#0,PK1D88#H3E*<>JJ^B_P#A/_E^A]\4&>I=
MTX'>^+Q%9%+MO%;DPU)F:3#&'1)$'I\A#40H4F#3:PH]<A/U)/L);;R3MJ7W
MC-"E-5>"?Q`_[[ZE[F'[RW.V^;*VQPW$R1^%HJ&G'^AM'Q%TPX-7X?R\NK_>
MO>O.[L'2TM+N'=6-J8:/Q4YAI8"::*GIX8$A@IX1^W%!"%]**`J_@>QU/806
M_@"S50BQCRID5]`/0=8]"XW*Y:\DW2[=[B:5Y*EF)H_^G)/&OK]O1H<?#6K$
MAJ)15RJ`))3&(^;+<!3]3S>_YO[2R27972E1Y>?3*VB02>-6I(K_`)?0>G3W
M&0+@@`W)_'^'MVU6<1MXY.K5\^%!Z].^,KN%\Z=([?N]-L=?;2W5OK>66H]N
M;2V;MK.;LW;N/(&9:'"[4VOCJK-[DRE5]JD]2\>+PE'45%A&Q`0D`GTE5II3
MIUK9I(RRG/\`GX>70:=1_(GIWOW^\)ZC[!QF[9]J-BI,[3"BSN*K\%3[DIJN
M3;.1K\'GL=MS*5&!SXQ=<M'6!7I*B>DF2*1W@E$5E8!2".F(HBNH2)J>OF*G
M[.'0UQLQD4Q3!Z=;/Q)]PLRS1ZHD=I9'DA>Y#J00&5@/=]2D?/\`(?X./6G:
M92!'"/V'_)TB]\]A;0ZRV'OSLGL7<N,VOL;K;:&?WSOK<=:/LJ3:^TMK87([
MAW'E\P4JIIH(,;@**2I)*C2L>I0Q-@W)0FHX=.1I-+%XDJT:II@C`IZU]?7I
M81Z9(XW$Z+$[R%OMUJZ..57B-))##)]Q&JU#5-C&201;TB_K]T\A3CTT@<N0
M2:?GTDJ/?>U\[E<7C\-EER[9:@R6<QE9AHJ_)8G(X_#5M+CZ[PYW'22X:*:@
MK*Q(9Z6276)""8QJ'M---*CJB4I2OG_DZ7O8OX/B_4:*'AJT^7&GF/F/\AZ5
M:@VD,#)(QE612@0)4+#(LCC6JK"ET<1,Y:Y*V/T(+B/<-0FO\^BT2W&O2+@.
M>`JQ.*]-_P#'<9-E6VZU4D6;?#G<,5/&DT]"F->H_A,-4V0DHACF<UTG$(=I
M+H&L5(NZ=8/>,]*B9#3Q`-5.O4^X\?4;ARNV:2:8Y;%XO`9NN@%#6"GI\7N+
M*[IQF(K4KGC7%URUE5M:I1Z>!A4P1Q!Y"%DB8ZZUT^PU$?B2I-3`U'H$AJ_N
M&$1:3T,JB12HB\H-@TK,I.GC@>_=>Z;\G4P4E+/+/41TZ4M+5U$E74UKT]/%
M10"*JJZBKR#JHH:>*(JK5')ITD+J?2??NO=('J'N?K+O;K_;G:W4F\\1OWKW
M>+9FGVQNG#^>GILI-A,UE<)E:.DARL=/D1DL/D,#605D4J+*):)SH6UA[KW7
M/?\`VQUMU1MO=.\M_;VPVW<)LC8N^NR-WYG(9*E63%;`ZP@FRW8.YWQ2&:JD
MPNU8R5KWAB\D(95!+:;>Z]T(=$ZR1"5(7^W,+-3RQRP-35L<I)2:GDBR-4&6
MH\?EB=]-HI47A@P'NO=>J9BT'GD98(`U-)')+)$((9%ECE"U;+*4*+/3JH>-
MVYEMI]-S[KW6K%\J?^$[W6_?/<_>VY,O_,J^9FU>G>[^X\EV#VE\4MF[@K=P
M;(Q&Z.]-\8K+4&'BVUC\M7XK;N"ER]4)*=\C@9W$<4,@J1#2R+[]U[J^+X1?
M"?X[?R\?CY@_C9\;-MR[>Z_VO6U>6JZ[-UM%7[OWKN7,FCHLENS?.>-!B?XK
MNS/18NDHQ4&**G:CH:6*G6.&*.-/=>Z,OGM\;9VE2Y1L_DX,;48W;&;WG68R
M*7S9HX/!K]]FZ^BQ-+$9*^*A%2@DEA5P\KE220??NO=*%*G[@JB5:I+4R2*L
M7^5PS_\``-I`3'.NNED2CE@E:/Q($D)Y)?W[KW7*.NAJH5FC:<4LD5-7>4+.
M7>GK(UD@\:0U(K85^MR8@GI86]+>_=>Z=?&?Z-_3_/S?[Z_OW7NO_]7?W*J3
M<@$_U(!/O=2.!ZJ41C5E!/V==^]=6I3AUP,:&]T0W^MU!O;^O'/U]Z*J>('6
MBJGBH/7>A1<A5YL#P.0/H#QS:_OP`&0*=;``X"G7E1$%D14']%4*/]L`/=BS
M'B2>ML2QU,:M\^N5A[UUKCCKK2O]!_MA[W4^O5=*@U"BO13/G5L;??9_PS^7
M'6756WJ7=7:'87Q?[YV-UQM>OKJ3$8[<^_-Y=7;KP&T<!6Y7*U6*Q%#3Y;<%
M53TTTLM7"(J>:1V9``Q]4^O3@=QP8_MZK0[8^*WR#AWUN#=F:VWVGV/MFC^4
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MX?94>([23`9>H[G^/FPMZXN#(UE7BJ6KB>KQM14I3Y&HECT54FI`KU9G=Q1W
M)'S->C(;0^'N^NQNYMD#*?'.OZJ^#<W?.]^RO]EOW3E.N<?MK;.$H?BQM_K>
M&3>74NV-Y[IV(NS=_=MY.LKXMDT\-?B:/)X-<W/145=633-8$K\)(Z:$<8-0
M@!^SH)<U\9_FMUWLK=^W-I]!YWN[:60VW\D-E]5=:UO8W455LGK3%=D_S&>V
M^Q^A=PML3>_>O7&U-PT/2OQ.S.#-#A%RE-'E&I:'`FJIJ:%SC_$DFI-3TX23
MQ/2FH_A3W;3]H=1[.PG7W<U'\4,%L_\`E]4&]*'LWN?9==NZ&JZ2W/\`S+=]
M_(B+L+#[.[%WCM[-9O<>=["ZO&?H,7]UMW<.,R$%!3.U!CDH<?KK77)_BKN?
MJGNG?A[4^,R]Q_!_';L^2&Y>COC?!D^F5Z7ZVR&>PWQSFV_N3=O6^_.R<9U^
M_7V1_NKNB3;M2]**38V1RM:6QT,]?!,?=>Z%3JC9'>W=_P#*7_EY]&;+7/;3
MJ/DS\9/C9MKY6=J_Q;$TFZ>ENF=S=`4>]?D'G\33;TR.6S60[*WYEUEV5A42
MFRAP&2W4N3J:5Z7%5"-[KW25V]\>/EA\4N]L10[;P/;?R*^+>W/E-D/DS%FL
M=/\`'+;>^\C5=U_%[OWJ7L/K=]B;.H.D]G#;NP.[<?A]Z7I\-C4JZC?D<ADR
M5?BZK[;W7NBS=F_"_P"3_9%/WMN'=_Q6W+G^Y.\/C!_-!Z=V%NO+=@=?Y6NZ
MPKN_?D[W-5=;;;SNY\7V_7M@MO[H^.F[<7D\-3T536QX.KJ6I(C3O&:2E]U[
MHT'R#^%O:6R>T=WYCXS;+WCM?X^9;!_#;*]J===1Y+J*EW5\B<MLGL3Y,UW?
M)IL?OW(UF'S?8T^`RNQ\GO"OS=+%4=@X^A7'O5Y1X)8(/=>Z5_5_P6HLQVGM
M"3MWK;M+L?XVX'H?NT8G8_R2S/0N13;/:'<??>&W;#M%>I^KI\5U1B<;L7#;
M.DK-D/%2U-1M"CW`^/@JJ(AJ*E]U[HI/0'PW^7'76/VOC<[U/F:/Y"5V7_E2
M97L'Y#TV[-DO2[YV-T)L7XP[3^5>.WAN2'L%MY[KS^+[,VKN/)5F-KH)*;-4
M#B4&NEE>ED]U[H=>O^I>Y-F?&CK+K>E^&24'<,PZUV?\X^V>R>N>E>[-Q]GY
M/"=7[PR6X>Y=H4$/;-)5_(G=.[^SL)C!%)NG(/-M^AW''4MB@:.KQ]-[KW1:
M,[\#?DMM3879&$Q/36]]]]VY[X3?S8^F/C1W33YKJ3:>Y.M.P>X?D;\DNUOC
M5M+(9C;?8V$V]UICL[UMNK;M#MA\`*?#;<6+[3RX:!(Z5/=>Z-_2=2=\P]IU
M&>CZ/W37?(.B^8W8O:E-\QZS<G5_]S,[\3GWEOW=NPNE\=N,=B2[ZAV?0]25
M^+ZYR.QY:*&AI\S#5[HAC<PBJF]U[H2OA9\.=Q?'+.?"3/U'6J8K?&$_E^;E
MZU^6W8LVZ,7E=Z;T^1'G^'5=@#V[G*?<#R=L;SKLCMG?:X_/SKD$Q$$E534<
MT%)D6BD]U[JW#5+_`,<#_P`"]7_`T_\``;_E:^O^;_YM?3W[KW7_UM_CW[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7!HXW8.T:,ZJR*S*I95=D9U#$$
MA6:)21]"5']![]U[KWCCU!_&FM;Z7TKJ&H*K6:UQJ5`#_4`?T]^Z]UT882Q8
MQ1EF\>IBBEF\,C2PW-KGQ2N67_4L21S[]U[KD$0*4"($8N64*`K&1F>0E0+$
MR,Q+?U)-_?NO=8S3P%54PPE51D53&A54<%711IL$938CZ$>_=>Z[$,(?R"*(
M/J9]8C37J<!6;5:^IE`!/U('OW7NN1BC(`,:$!F8`HI`9PX=@".&<2,"?R&/
M]??NO==LB-8LJM8@C4H-B&5P1<<$,@/^N!_3W[KW7'PPV5?%'I41A5T+91"P
M>$*+6`B<`K_J2+CW[KW06]D]$=']RKMI.W^FNJ>U4V95U60V>O9/7FT=\KM2
MOKJ>.DKJW;2[GP^4&"JZREB6*62E\3R1J%8D`#W[KW0HK!`@54AB54T:56-%
M"^,:8](``'C7A;?0?3W[KW7/0ITDJI*'4G`]+:2FI>/2=#$7'X-O?NO=>"(#
M<*H/]0HO]6/UM?ZN?]N?Z^_=>ZY6_/Y^E_\`6O;_`&U_?NO=<51$MH1%L`HT
MJ%LH```L!8`*!_K#W[KW71BC9D9HT9HW,L;%%+)(8VA,B$BZN8G9;CG22/H?
M?NO=<!3TX\9$$(,,+T\5HD'B@D\>N"/T^B%_"EU%E.@<<#W[KW7(PPMKU11M
MY0RR713Y`ZHCA[CUATC4&_U"@?@>_=>Z[\::BVA-1;66TC46TA-1-KZM"@7^
MMA;W[KW7>A`Q?0NLA5+Z1J*JS,JEK7(5G)`_!)]^Z]UP\$'_`!QB_P`[Y_\`
M-I_G_P#CM]/\[_M7U]^Z]U__U]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
'[W[KW7__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
